Tags

Type your tag names separated by a space and hit enter

Rubeosis iridis after vitrectomy for diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol. 1998 Oct; 236(10):730-3.GA

Abstract

BACKGROUND

Iris rubeosis and neovascular glaucoma (NVG) are serious complications of vitrectomy for proliferative diabetic retinopathy. The present study analyzes incidence and risk factors of these complications.

METHODS

Preoperative and postoperative iris rubeosis were compared in 389 diabetic eyes after vitrectomy. Minimum follow-up was 6 months (median 26 months). Risk factors were studied using multivariate logistic regression analysis.

RESULTS

Following vitrectomy, in 8.5% of the eyes stromal iris rubeosis developed de novo; NVG occurred in 5%. Significant risk factors for postoperative rubeosis were preexisting iris neovascularizations and postoperative retinal detachment. Six months after surgery, regression of preexisting iris rubeosis was observed in 57% of the eyes. In eyes without preoperative iris rubeosis, progression was found in 13% of cases 6 months postoperatively.

CONCLUSION

With current surgical techniques iris rubeosis is more commonly regressive than progressive after vitreous surgery in diabetic eyes.

Authors+Show Affiliations

Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9801886

Citation

Helbig, H, et al. "Rubeosis Iridis After Vitrectomy for Diabetic Retinopathy." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, vol. 236, no. 10, 1998, pp. 730-3.
Helbig H, Kellner U, Bornfeld N, et al. Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1998;236(10):730-3.
Helbig, H., Kellner, U., Bornfeld, N., & Foerster, M. H. (1998). Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 236(10), 730-3.
Helbig H, et al. Rubeosis Iridis After Vitrectomy for Diabetic Retinopathy. Graefes Arch Clin Exp Ophthalmol. 1998;236(10):730-3. PubMed PMID: 9801886.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rubeosis iridis after vitrectomy for diabetic retinopathy. AU - Helbig,H, AU - Kellner,U, AU - Bornfeld,N, AU - Foerster,M H, PY - 1998/11/5/pubmed PY - 1998/11/5/medline PY - 1998/11/5/entrez SP - 730 EP - 3 JF - Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie JO - Graefes Arch Clin Exp Ophthalmol VL - 236 IS - 10 N2 - BACKGROUND: Iris rubeosis and neovascular glaucoma (NVG) are serious complications of vitrectomy for proliferative diabetic retinopathy. The present study analyzes incidence and risk factors of these complications. METHODS: Preoperative and postoperative iris rubeosis were compared in 389 diabetic eyes after vitrectomy. Minimum follow-up was 6 months (median 26 months). Risk factors were studied using multivariate logistic regression analysis. RESULTS: Following vitrectomy, in 8.5% of the eyes stromal iris rubeosis developed de novo; NVG occurred in 5%. Significant risk factors for postoperative rubeosis were preexisting iris neovascularizations and postoperative retinal detachment. Six months after surgery, regression of preexisting iris rubeosis was observed in 57% of the eyes. In eyes without preoperative iris rubeosis, progression was found in 13% of cases 6 months postoperatively. CONCLUSION: With current surgical techniques iris rubeosis is more commonly regressive than progressive after vitreous surgery in diabetic eyes. SN - 0721-832X UR - https://www.unboundmedicine.com/medline/citation/9801886/Rubeosis_iridis_after_vitrectomy_for_diabetic_retinopathy_ L2 - https://dx.doi.org/10.1007/s004170050150 DB - PRIME DP - Unbound Medicine ER -